Molecular Formula | C25H19N3O |
Molar Mass | 377.44 |
Density | 1.21±0.1 g/cm3(Predicted) |
Boling Point | 538.4±60.0 °C(Predicted) |
pKa | 6.33±0.40(Predicted) |
Storage Condition | -20℃ |
Use | Diphenylterazine is a biological luminous agent. |
In vitro study | Diphenylterazine elicits minimal cell toxicity at millimolar concentrations. Notes : To make a stock solution for DTZ (Diphenylterazine), first, a premixture is prepared by dissolving 17.6 mg of L-ascorbic acid (HY-B0166) in 10 mL ethanol and 10 mL 1,2-propanediol; next, 1 mg of DTZ is dissolved in 88 µL of the premix, resulting in a 30 mM DTZ stock solution containing 5 mM L-ascorbic acid. |
In vivo study | Diphenylterazine injections into untransfected BALB/c mice do not yield any background emission. The bioluminescence resulting from intraperitoneally injected Diphenylterazine displays extended kinetics. DTZ (0.3 μmol/mouse; i.v.) treatment can track tumor growth in a xenograft NU/J mouse model. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.649 ml | 13.247 ml | 26.494 ml |
5 mM | 0.53 ml | 2.649 ml | 5.299 ml |
10 mM | 0.265 ml | 1.325 ml | 2.649 ml |
5 mM | 0.053 ml | 0.265 ml | 0.53 ml |